GDG meetingDeclaration of Interests
First GDG meeting
(12th December 2007)
JS declared a personal pecuniary interest, he is a member of advisory boards on LUTS and received honoraria from Boehringer Ingeliheim (March 07). He has attended advisory boards on Restless legs syndrome organised by RLS UK with payment from Boehringer Ingelheim. He has been paid for attendance at a focus group on faecal incontinence by Continence UK (Nov 07). He has been paid to speak and chair meetings by Astellas, BMS and ALK. He is a paid member of the editorial boards of Continence UK. He has received payment for attending focus meetings on child growth hormone. He did not declare a personal family interest of non-personal pecuniary interest. He declared a personal non-pecuniary interest, member of the strategy board of Incontact, Chairman of the local division of the BMA and board member of RLS UK.
Second GDG Meeting
(13th December 2007)
No change
Third GDG Meeting
(17th March 2008)
No change
Fourth GDG Meeting
(30th April 2008)
JS declared a personal pecuniary interest, I have received sponsorship to attend the EAU congress in Milan from Pfizer. I have received speaker fees to speak at a conference from Pfizer on GPs and OAB. He is a member of advisory boards on LUTS and received honoraria from Boehringer Ingeliheim (March 07). He has attended advisory boards on Restless legs syndrome organised by RLS UK with payment from Boehringer Ingelheim. He has been paid for attendance at a focus group on faecal incontinence by Continence UK (Nov 07). He has been paid to speak and chair meetings by Astellas, BMS and ALK. He is a paid member of the editorial boards of Continence UK. He has received payment of attending focus meetings on child growth hormone. He did not declare a personal family interest of non-personal pecuniary interest. He declared a personal non-pecuniary interest, member of the strategy board of Incontact, Chairman of the local division of the BMA and board member of RLS UK.
Fifth GDG Meeting
(6th June 2008)
No change
Sixth GDG Meeting
(14th July 2008)
No change
Seventh GDG Meeting
(8th September 2008)
No change
Eighth GDG Meeting
(15th October 2008)
No change
Ninth GDG Meeting
(27th November 2008)
No change
Tenth GDG Meeting
(16th January 2009)
JS declared a personal non-pecuniary interest, he attended a planning meeting for the “Sense of Leadership” organised by Pfizer. He declared that he knew of no personal pecuniary interest, personal family interest or non-personal pecuniary interest, above those declared at the previous meeting.
Eleventh GDG Meeting
(23rd February 2009)
No change
Twelfth GDG Meeting
(25th March 2009)
No change
Thirteenth GDG Meeting
(1st May 2009)
JS declared that he had no current personal pecuniary interests. He declared that he knew of no non-personal family interest, personal non-pecuniary interest or personal family interest, above those declared at the previous meeting.
Fourteenth GDG Meeting
(8th June 2009)
No change
Fifteenth GDG Meeting
(29th June 2009)
No change
ActionsDuring the 12th GDG on the 25th March 2009, JS was only present as an observer for the presentations on medical interventions and did not participate in discussion due to previously declared interest.

From: Appendix B, Declarations of interests

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.